Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EPS (Weighted Average and Diluted) (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$0.54 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 58.82% to -$0.54 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.72, a 1.71% increase, with the full-year FY2025 number at -$1.72, up 1.71% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.54 for Q4 2025 at PROCEPT BioRobotics, down from -$0.38 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.01 in Q4 2021 to a low of -$2.65 in Q1 2021.
  • A 5-year average of -$0.57 and a median of -$0.5 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 148.19% in 2021, then plummeted 131.34% in 2022.
  • PROCEPT BioRobotics' EPS (Weighted Average and Diluted) stood at $2.01 in 2021, then tumbled by 131.34% to -$0.63 in 2022, then rose by 14.29% to -$0.54 in 2023, then soared by 37.04% to -$0.34 in 2024, then plummeted by 58.82% to -$0.54 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's EPS (Weighted Average and Diluted) are -$0.54 (Q4 2025), -$0.38 (Q3 2025), and -$0.35 (Q2 2025).